Clinical Trial Update: Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy [Phase 2]

View source ↗

Summary

Phase 2 study assessing the safety and efficacy of the IBE-814 dexamethasone intravitreal implant for diabetic macular edema and macular edema due to retinal ve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Macular Edema Due to Retinal Vein Occlusion

Drugs mentioned

• IBE-814 Intravitreal Implant (dexamethasone)

Snippet

Sponsor: Ripple Therapeutics Pty Ltd | Conditions: Diabetic Macular Oedema, Retinal Vein Occlusion with Macular Oedema | Phase 2 | Status: COMPLETED